The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System
Open accessAbstract
Previous studies have demonstrated that repeated forced-swim stress-induced behaviors (including analgesia, immobility, and increased drug reward) were mediated by the release of endogenous prodynorphin-derived opioid peptides and subsequent activation of the kappa opioid receptor (KOR). We tested the generality of these effects using a different type of stressful situation: repeated social defeat. C57Bl/6 mice subjected to social defeat stress (SDS) over 3 days showed a characteristic stress-induced immobility and defeated-postural response, as well as stress-induced analgesia (SIA). Daily pretreatment with the KOR antagonist nor-binaltorphimine (nor-BNI, 10 mg/kg, i.p.) blocked the SIA and significantly reduced the stress-induced immobility on the second and third days of SDS exposure. In contrast, prodynorphin gene-disrupted mice showed no significant increase in immobility, socially defeated postures, or SIA following repeated exposure to SDS. Since both stress and the kappa opioid system can modulate the response to drugs of abuse, we tested the effects of SDS on cocaine-conditioned place preference (CPP). SDS-exposed mice conditioned with cocaine (15 mg/kg, s.c.) showed significant potentiation of place-preference for the drug-paired chamber over the responses of unstressed mice. Nor-BNI pretreatment blocked stress-induced potentiation of cocaine-CPP. Consistent with this result, mice lacking the prodynorphin gene did not show stress-induced potentiation of cocaine-CPP, whereas wild-type littermates did. The findings suggest that chronic SDS may activate the kappa opioid system to produce analgesia, immobility, social defeat postures, and resulting in a potentiation of the acute rewarding properties of cocaine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In some species or strains within species, however, tonic immobility may be the front-line defense response to extreme threat, even when the animal is not restrained.8,26,86”
From Fear and the Defense Cascade (2015) · cites this paper as [86]
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.
Spanagel, R., Herz, A., & Shippenberg, T. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2046 · Cited by 1,005
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
Stress-induced relapse to heroin and cocaine seeking in rats: a review
Shaham, Y., Erb, S. M., & Stewart, J. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00024-2 · Cited by 704
Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509
McLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 505
Self-citationSocial defeat as a stressor in humans
Björkqvist, K. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00490-5 · Cited by 502
Lucki, I., Dalvi, A., & Mayorga, A. J. (2001) · Psychopharmacology · doi:10.1007/s002130100694 · Cited by 501
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague, S. D., Pliakas, A. M., Todtenkopf, M. S., Tomasiewicz, H. C., Zhang, Y., Stevens, W. C., Jones, R. M., Portoghese, P. S., & Carlezon, W. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046433 · Cited by 485
Cited by
Sorted by citations
Items 101–200 of 255
García-Pardo, M. P., Blanco-Gandía, M. C., Valiente-Lluch, M., Rodríguez‐Arias, M., Miñarro, J., & Aguilar, M. A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.006 · Cited by 53
Verhoest, P. R., Basak, A. S., Parikh, V. D., Hayward, M. M., Kauffman, G. W., Paradis, V., McHardy, S. F., McLean, S., Grimwood, S., Schmidt, A. W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2006035 · Cited by 53
Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice
Almatroudi, A., Husbands, S. M., Bailey, C. P., & Bailey, S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115586937 · Cited by 49
Montagud‐Romero, S., Núñez, C., Blanco-Gandía, M. C., Laorden, E. M., Aguilar, M. A., Zaragoza, J. N., Almela, P., Milanés, M. V., Laorden, M. L., Miñarro, J., et al. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4612-y · Cited by 49
Williams, A. V., Laman-Maharg, A., Armstrong, C. V., Ramos-Maciel, S., Minie, V. A., & Trainor, B. C. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.06.001 · Cited by 50
Muschamp, J. W., Nemeth, C. L., Robison, A. J., Nestler, E. J., & Carlezon, W. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.08.011 · Cited by 50
Drug withdrawal conceptualized as a stressor
Chartoff, E. H., & Carlezon, W. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000080 · Cited by 44
LeRoy, A. S., Knee, C. R., Derrick, J. L., & Fagundes, C. P. (2019) · Personality and Social Psychology Review · doi:10.1177/1088868319853895 · Cited by 48
Kappa Opioids, Salvinorin A and Major Depressive Disorder
Taylor, G. T., & Manzella, F. M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150727220944 · Cited by 44
Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
Laman-Maharg, A., Williams, A. V., Zufelt, M. D., Minie, V. A., Ramos-Maciel, S., Hao, R., Sanchez, E. O., Copeland, T., Silverman, J. L., Leigh, A., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00093 · Cited by 43
Murra, D., Hilde, K. L., Fitzpatrick, A., Maras, P. M., Watson, S. J., & Akil, H. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100437 · Cited by 48
Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression
Hache, G., Guiard, B. P., Dantec, Y. L., Orvoën, S., David, D. J. P., Gardier, A. M., & Coudoré, F. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328353d70a · Cited by 47
Social defeat stress: Mechanisms underlying the increase in rewarding effects of drugs of abuse
Montagud‐Romero, S., Blanco-Gandía, M. C., Reguilón, M. D., Perez, C. F., Ballestín, R., Miñarro, J., & Rodríguez‐Arias, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14127 · Cited by 40
Rodríguez‐Arias, M., Montagud‐Romero, S., Carrión, A. M. G., Perez, C. F., Pérez‐Villalba, A., Marco, E. M., López‐Gallardo, M., Viveros, M., & Miñarro, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206421 · Cited by 42
Beardsley, P. M., Pollard, G. T., Howard, J. L., & Carroll, F. I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1846-3 · Cited by 40
The impact of sex as a biological variable in the search for novel antidepressants
Williams, A. V., & Trainor, B. C. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.05.003 · Cited by 42
Oxytocin prevents the increase of cocaine-related responses produced by social defeat
Perez, C. F., Castro‐Zavala, A., Luján, M. Á., Filarowska, J., Ballestín, R., Miñarro, J., Valverde, O., & Rodríguez‐Arias, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.011 · Cited by 40
Solecki, W., Ziolkowska, B., Krowka, T., Gieryk, A., Filip, M., & Przewlocki, R. (2009) · Brain Research · doi:10.1016/j.brainres.2008.12.002 · Cited by 39
Matuskey, D., Dias, M., Naganawa, M., Pittman, B. P., Henry, S. E., Li, S., Gao, H., Ropchan, J. R., Nabulsi, N., Carson, R. E., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0379-7 · Cited by 39
Self-citationNakamoto, K., & Tokuyama, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411713 · Cited by 41
Biała, G., Pękała, K., Boguszewska‐Czubara, A., Michalak, A., Kruk-Słomka, M., Grot, K., & Budzyńska, B. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0585-4 · Cited by 39
Fukushiro, D. F., Carvalho, R. C., Ricardo, V. P., Alvarez, J. D. N., Ribeiro, L. T. C., & Frussa‐Filho, R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.05.004 · Cited by 36
Stress, sex, and motivated behaviors
Laman-Maharg, A., & Trainor, B. C. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23815 · Cited by 36
Selective kappa opioid antagonists for treatment of addiction, are we there yet?
Helal, M. A., Habib, E. S., & Chittiboyina, A. G. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.012 · Cited by 36
Zan, G., Wang, Q., Wang, Y., Liu, Y., Hang, A., Shu, X. H., & Liu, J. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.05.053 · Cited by 35
Interplay between the oxytocin and opioid systems in regulating social behaviour
Putnam, P. T., & Chang, S. W. C. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0050 · Cited by 33
Kappa opioid receptor binding in major depression: A pilot study
Miller, J. M., Zanderigo, F., Purushothaman, P. D., DeLorenzo, C., Rubin‐Falcone, H., Ogden, R. T., Keilp, J. G., Oquendo, M. A., Nabulsi, N., Huang, Y. H., et al. (2018) · Synapse · doi:10.1002/syn.22042 · Cited by 34
Yoo, J. H., Kitchen, I., & Bailey, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01952.x · Cited by 34
Zhukovskaya, A., Zimmerman, C. A., Willmore, L., Pan-Vazquez, A., Janarthanan, S. R., Lynch, L. A., Falkner, A. L., & Witten, I. B. (2024) · Neuron · doi:10.1016/j.neuron.2024.09.009 · Cited by 33
Greenwald, M. K. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.08.003 · Cited by 33
Social Defeat Stress, Sex, and Addiction-Like Behaviors
Shimamoto, A. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.009 · Cited by 36
Advances in novel molecular targets for antidepressants
Wang, Q., & Dwivedi, Y. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110041 · Cited by 33
Eisinger, B. E., Zhao, C., Driessen, T. M., Saul, M. C., & Gammie, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063824 · Cited by 31
Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Escobar, A. P., Casanova, J. P., Andrés, M. E., & Fuentealba, J. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00057 · Cited by 32
Resilience to Stress and Resilience to Pain: Lessons from Molecular Neurobiology and Genetics
Nestler, E. J., & Waxman, S. G. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.03.007 · Cited by 33
Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc
Flaisher-Grinberg, S., Persaud, S. D., Loh, H. H., & Wei, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205565109 · Cited by 31
KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway
Estave, P. M., Spodnick, M. B., & Karkhanis, A. N. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_421 · Cited by 30
Huang, P., Tunis, J., Parry, C., Tallarida, R. J., & Liu‐Chen, L. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.061 · Cited by 29
Opioids in cancer: The κ‑opioid receptor (Review)
Zhou, Q., Zhang, Z., Long, S., Li, W., Wang, B., & Liang, N. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12560 · Cited by 29
Friend of the Devil: Negative Social Influences Driving Substance Use Disorders
Pomrenze, M. B., Paliarin, F., & Maiya, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.836996 · Cited by 29
García-Pardo, M. P., Rodríguez‐Arias, M., Maldonado, C., Manzanedo, C., Miñarro, J., & Aguilar, M. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000065 · Cited by 28
Yet, L. (2018) · Wiley eBooks · doi:10.1002/9781118686263.ch4 · Cited by 28
The Role of The Rostral Ventromedial Medulla in Stress Responses
Pagliusi, M., & Gomes, F. V. (2023) · Brain Sciences · doi:10.3390/brainsci13050776 · Cited by 28
Wulf, H. A., Browne, C. A., Zarate, C. A., & Lucki, I. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06118-4 · Cited by 27
Tovar-Díaz, J., Pomrenze, M. B., Pahlavan, B., Kan, R., Drew, M. R., & Morikawa, H. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.039 · Cited by 29
Bailey, C. P., & Husbands, S. M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.964203 · Cited by 25
Depression and substance use comorbidity: What we have learned from animal studies
Ng, E., Browne, C. J., Samsom, J., & Wong, A. H. C. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1183020 · Cited by 26
Rosa, S. G., Pesarico, A. P., & Nogueira, C. W. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.021 · Cited by 24
Almatroudi, A., Ostovar, M., Bailey, C. P., Husbands, S. M., & Bailey, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14060 · Cited by 23
Varlinskaya, E. I., SPEAR, L. P., & Diaz, M. R. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.003 · Cited by 23
Rogala, B., Li, Y., Li, S., Chen, X., & Kirouac, G. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049669 · Cited by 23
Self-citationFemenía, T., Pérez-Rial, S., Urigüen, L., & Manzanares, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367724 · Cited by 23
Baugher, B. J., Buckhaults, K., Case, J. M., Sullivan, A., Huq, S. N., & Sachs, B. D. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113811 · Cited by 22
Adžić, M., Lukić, I., Mitić, M., Glavonic, E., Dragicevic-Curic, N., & Ivković, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121803 · Cited by 22
Tokuyama, S., Nagae, R., Mashida, E., & Hamabe, W. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.8.0008 · Cited by 22
Bailey, S., & Husbands, S. M. (2018) · Neuronal Signaling · doi:10.1042/ns20170145 · Cited by 24
Laman-Maharg, A., Copeland, T., Sanchez, E. O., Campi, K. L., & Trainor, B. C. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.015 · Cited by 21
García-Pardo, M. P., Calpe-López, C., Miñarro, J., & Aguilar, M. A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.025 · Cited by 21
Modulation of nociception by social factors in rodents: contribution of the opioid system
D'Amato, F. R., & Pavone, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2863-1 · Cited by 22
Lucas, L., Dragisic, T., Duwaerts, C. C., Swiatkowski, M., & Suzuki, H. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.06.017 · Cited by 21
Kappa opioid receptor controls neural stem cell differentiation via a miR-7a/Pax6 dependent pathway
Xu, C., Fan, W., Zhang, Y., Loh, H. H., & Law, P. (2021) · Stem Cells · doi:10.1002/stem.3334 · Cited by 18
Fontaine, H. M., Silva, P. R., Neiswanger, C., Tran, R., Abraham, A. D., Land, B. B., Neumaier, J. F., & Chavkin, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01178-0 · Cited by 24
Self-citationPanksepp, J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_458 · Cited by 22
Brain-region-specific Molecular Responses to Maternal Separation and Social Defeat Stress in Mice
Sachs, B. D., Tran, H. L., Folse, E., & Caron, M. G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.018 · Cited by 19
Buprenorphine: prospective novel therapy for depression and PTSD
Madison, C. A., & Eitan, S. (2020) · Psychological Medicine · doi:10.1017/s0033291720000525 · Cited by 21
Hymel, K. A., Eans, S. O., Sitchenko, K. L., Gomes, S. M., Lukowsky, A. L., Medina, J. M., Sypek, E. I., Carey, A. N., & McLaughlin, J. P. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000074 · Cited by 18
Self-citationDynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry
Tejeda, H. A., Wang, H., Flores, R. J., & Yarur, H. E. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_440 · Cited by 18
Bales, K. L., & Rogers, F. D. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0061 · Cited by 17
Kappa Opioid Receptor Function
Lemos, J. C., & Chavkin, C. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_11 · Cited by 17
Self-citationSpodnick, M. B., Amirault, R. T., Towner, T. T., Varlinskaya, E. I., SPEAR, L. P., & Karkhanis, A. N. (2020) · Brain Sciences · doi:10.3390/brainsci10080472 · Cited by 15
Talishinsky, A., & Rosen, G. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044236 · Cited by 17
Magnusson, K. A., Birgner, C., Bergström, L., Nyberg, F., & Hallberg, M. (2009) · Neuropeptides · doi:10.1016/j.npep.2008.12.005 · Cited by 17
Opioid modulation of prefrontal cortex cells and circuits
Cole, R. H., Moussawi, K., & Joffe, M. E. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109891 · Cited by 16
Zhang, L., McCarthy, D. M., Jaunarajs, K. L. E., Biederman, J., Spencer, T. J., & Bhide, P. G. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa238 · Cited by 16
The Brain Emotional Systems in Addictions: From Attachment to Dominance/Submission Systems
Giacolini, T., Conversi, D., & Alcaro, A. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.609467 · Cited by 19
In vivo and in vitro characterization of naltrindole-derived ligands at the κ-opioid receptor
Casal-Dominguez, J. J., Clark, M. J., Traynor, J. R., Husbands, S. M., & Bailey, S. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112464828 · Cited by 17
Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes
Bryant, C. D., Zaki, P. A., Carroll, F. I., & Evans, C. J. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.006 · Cited by 16
Cocaine self-administration and locomotor sensitization are not altered in CART knockout mice
Steiner, R. C., Hsiung, H. M., & Picciotto, M. R. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.022 · Cited by 15
Riters, L. V., Cordes, M. A., & Stevenson, S. A. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.11.050 · Cited by 14
Rosa, S. G., Pesarico, A. P., Martini, F., & Nogueira, C. W. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1024-x · Cited by 14
Pierzchała, K., Dziedzicka‐Wasylewska, M., Oeltgen, P. R., Zubel–Łojek, J., Latacz, A., & Oclon, E. A. (2015) · Folia Biologica · doi:10.3409/fb63_3.187 · Cited by 13
Blanco-Gandía, M. C., Montagud‐Romero, S., Navarro‐Zaragoza, J., Laorden, E. M., Almela, P., Núñez, C., Milanés, M. V., Laorden, M. L., Miñarro, J., & Rodríguez‐Arias, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05256-6 · Cited by 12
González-Portilla, M., Moya, M., Montagud‐Romero, S., de Fonseca, F. R., Orío, L., & Rodríguez‐Arias, M. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110722 · Cited by 12
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Bershad, A. K., & de Wit, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad094 · Cited by 12
Karkhanis, A. N., West, A. M., & Jones, S. R. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13929 · Cited by 12
Caputi, F. F., Caffino, L., Candeletti, S., Fumagalli, F., & Romualdi, P. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.01.006 · Cited by 12
Wright, E. C., Parks, T. V., Alexander, J. O., Supra, R., & Trainor, B. C. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.011 · Cited by 13
Robinson, S. A., Hill‐Smith, T. E., & Lucki, I. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100182 · Cited by 11
Grochecki, P., Smaga, I., Wydra, K., Marszałek‐Grabska, M., Słowik, T., Kędzierska, E., Listos, J., Gibuła‐Tarłowska, E., Filip, M., & Kotlinska, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031941 · Cited by 10
Opioid Mechanisms and the Treatment of Depression
Jelen, L. A., Young, A. H., & Mehta, M. A. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_448 · Cited by 10
Khan, M. I., Shirzadian, A., Haj‐Mirzaian, A., Mehr, S. E., Dehpour, A. R., Rahimi-Balaei, M., & Amiri, S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.01.041 · Cited by 10
Iñiguez, S. D., Flores‐Ramirez, F. J., Themann, A., & Lira, O. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02221-9 · Cited by 12
Clark, S. D. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_396 · Cited by 10
A review of kappa opioid receptor antagonists and their clinical trial landscape
Lobe, M. M. M., Verma, S. K., Patil, V. M., & Iyer, M. R. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117205 · Cited by 9
Solms, M. (2012) · PsycEXTRA Dataset · doi:10.1037/e579192013-150 · Cited by 9
Yet, L. (2018) · doi:10.1002/9781118686263.ch10 · Cited by 9
Chiba, S., Numakawa, T., Murata, T., Kawaminami, M., & Himi, T. (2022) · Journal of Veterinary Medical Science · doi:10.1292/jvms.22-0103 · Cited by 8
Varastehmoradi, B., Smith, K. L., Müller, H. K., Elfving, B., Sánchez, C., & Wegener, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.03.010 · Cited by 8
Khaloo, P., Sadeghi, B., Ostadhadi, S., Norouzi‐Javidan, A., Haj‐Mirzaian, A., Zolfagharie, S., & Dehpour, A. R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.015 · Cited by 8
Mehranfard, N., Ghasemi, M., & Saboory, E. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.70065 · Cited by 7
Metadata
- Authors
- McLaughlin, J. P., Li, S., Valdez, J., Chavkin, T. A., & Chavkin, C.
- Affiliations
- Northeastern University (US)
- University of Washington (US)
- Corresponding author
- Chavkin, Charles
- Venue
- Neuropsychopharmacology
- Published
- 2005-08-17
- Volume
- 31
- Issue
- 6
- Pages
- 1241-1248
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC2096774
- OpenAlex
- W2023872238
- Cited by
- 253
- References
- 43
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 5 · 2023: 11 · 2022: 11 · 2021: 9 · 2020: 16 · 2019: 10 · 2018: 26 · 2017: 12 · 2016: 10 · 2015: 17 · 2014: 12 · 2013: 14 · 2012: 21
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5p01da015916-05)
- U.S. Public Health Service
- National Institute on Drug Abuse (R01DA11672, P01DA15916, R01DA016898, P01-DA015916, R03DA016656, R01DA011672, R03 DA 16656)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- social defeat stress, kappa opioid receptor, nor-binaltorphimine, prodynorphin, stress-induced analgesia, immobility, cocaine conditioned place preference, endogenous opioids, chronic stress
- MeSH terms
- Analysis of Variance, Anesthetics, Local, Animals, Behavior, Animal, Cocaine, Conditioning, Operant, Enkephalins, Male, Mice, Inbred C57BL, Naltrexone, Narcotic Antagonists, Pain Measurement, Protein Precursors, Reaction Time, Social Behavior, Stress, Psychological, Receptors, Opioid, kappa, Mice, Knockout, Immobility Response, Tonic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review